Patent details

EP3195880 Title: HIGH CONCENTRATION ANTI-SCLEROSTIN ANTIBODY FORMULATIONS

Basic Information

Publication number:
EP3195880
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP171589906
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
HIGH CONCENTRATION ANTI-SCLEROSTIN ANTIBODY FORMULATIONS
French Title of Invention:
FORMULATIONS D'ANTICORPS ANTI-SCLEROSTIN HAUTEMENT CONCENTREE
German Title of Invention:
HOCH-KONZENTRIERTE ANTI-SCLEROSTIN ANTIKÖRPERFORMULIERUNGEN
SPC Number:

Dates

Filing date:
11/05/2011
Grant date:
27/11/2019
EP Publication Date:
26/07/2017
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
27/11/2019
EP B1 Publication Date:
27/11/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
11/05/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
20/11/2019
 
 

Name:
Amgen Inc.
Address:
One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
02/12/2019
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
OSSLUND, Timothy, D.
Address:
United States (US)

Priority

Priority Number:
334986 P
Priority Date:
14/05/2010
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/395; A61K 47/12; C07K 16/22;

Publication

European Patent Bulletin

Issue number:
201948
Publication date:
27/11/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
01/06/2026
Annual Fee Number:
16
Annual Fee Amount:
230 Euro
Expected Payer:
Last Annual Fee Payment Date:
29/04/2025
Last Annual Fee Paid Number:
15
Last Annual Fee Paid Amount:
213 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
02/12/2019 Outgoing Correspondence 1
02/12/2019 Power Of Attorney 1